Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, Medhus S, Tanum L, Franck J.

BMC Psychiatry. 2012 Dec 5;12:221. doi: 10.1186/1471-244X-12-221. Review.

PMID:
23216941
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].

Härtel-Petri R, Rodler R, Schmeisser U, Steinmann J, Wolfersdorf M.

Psychiatr Prax. 2005 Jan;32(1):13-7. German.

PMID:
15633070
[PubMed - indexed for MEDLINE]
3.

Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.

Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Hsiao CC, Chiang YL, Ree SC, Lee CH, Murray RM.

Psychol Med. 2003 Nov;33(8):1407-14.

PMID:
14672249
[PubMed - indexed for MEDLINE]
4.

Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.

Niemi-Pynttäri JA, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola SP.

J Clin Psychiatry. 2013 Jan;74(1):e94-9. doi: 10.4088/JCP.12m07822.

PMID:
23419236
[PubMed - indexed for MEDLINE]
5.

Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.

Arendt M, Mortensen PB, Rosenberg R, Pedersen CB, Waltoft BL.

Arch Gen Psychiatry. 2008 Nov;65(11):1269-74. doi: 10.1001/archpsyc.65.11.1269.

PMID:
18981338
[PubMed - indexed for MEDLINE]
6.

[Risk factors of schizophrenia development in patients with amphetamines dependence and psychosis (amphetamine-induced psychosis and schizophrenia), and without psychosis].

Rabe-Jabłońska J, Mirek M, Pawełczyk T.

Psychiatr Pol. 2012 Jul-Aug;46(4):571-84. Polish.

PMID:
23214160
[PubMed - indexed for MEDLINE]
7.

Six months follow-up of patients with methamphetamine psychosis.

Yeh HS, Lee YC, Sun HJ, Wan SR.

Zhonghua Yi Xue Za Zhi (Taipei). 2001 Jul;64(7):388-94.

PMID:
11584576
[PubMed - indexed for MEDLINE]
8.

Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.

Yui K, Ikemoto S, Ishiguro T, Goto K.

Ann N Y Acad Sci. 2000 Sep;914:1-12. Review.

PMID:
11085303
[PubMed - indexed for MEDLINE]
9.

Amphetamine psychosis: a model for studying the onset and course of psychosis.

Hermens DF, Lubman DI, Ward PB, Naismith SL, Hickie IB.

Med J Aust. 2009 Feb 16;190(4 Suppl):S22-5. Review.

PMID:
19220169
[PubMed - indexed for MEDLINE]
10.

An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.

Jacobs E, Fujii D, Schiffman J, Bello I.

Cogn Behav Neurol. 2008 Jun;21(2):98-103. doi: 10.1097/WNN.0b013e31816bdf90.

PMID:
18541986
[PubMed - indexed for MEDLINE]
11.

When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders.

Caton CL, Samet S, Hasin DS.

J Psychiatr Pract. 2000 Sep;6(5):256-66.

PMID:
15990489
[PubMed]
12.

Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.

Ikeda M, Okahisa Y, Aleksic B, Won M, Kondo N, Naruse N, Aoyama-Uehara K, Sora I, Iyo M, Hashimoto R, Kawamura Y, Nishida N, Miyagawa T, Takeda M, Sasaki T, Tokunaga K, Ozaki N, Ujike H, Iwata N.

Neuropsychopharmacology. 2013 Sep;38(10):1864-70. doi: 10.1038/npp.2013.94. Epub 2013 Apr 12.

PMID:
23594818
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements.

Mikami T, Naruse N, Fukura Y, Ohkubo H, Ohkubo T, Matsuura M, Moriya H, Nishikawa T, Kojima T.

Psychiatry Clin Neurosci. 2003 Aug;57(4):433-40.

PMID:
12839526
[PubMed - indexed for MEDLINE]
14.

Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.

Kishi T, Tsunoka T, Ikeda M, Kitajima T, Kawashima K, Okochi T, Okumura T, Yamanouchi Y, Kinoshita Y, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Iwata N.

Neuropharmacology. 2010 Feb;58(2):452-6. doi: 10.1016/j.neuropharm.2009.09.006. Epub 2009 Sep 10.

PMID:
19747927
[PubMed - indexed for MEDLINE]
15.

Hostility among methamphetamine users experiencing psychotic symptoms.

McKetin R, McLaren J, Lubman DI, Hides L.

Am J Addict. 2008 May-Jun;17(3):235-40. doi: 10.1080/10550490802019816.

PMID:
18464001
[PubMed - indexed for MEDLINE]
16.

[Does chronic psychosis due to amphetamines abuse exist? Study of 25 drug addicts].

Charles-Nicolas AJ.

Nouv Presse Med. 1976 Nov 6;5(37):2447-50. French.

PMID:
980758
[PubMed - indexed for MEDLINE]
17.

Substance misuse and early psychosis.

Tucker P.

Australas Psychiatry. 2009 Aug;17(4):291-4. doi: 10.1080/10398560802657314. Review.

PMID:
19301164
[PubMed - indexed for MEDLINE]
18.

When does amphetamine-induced psychosis become schizophrenia?

Flaum M, Schultz SK.

Am J Psychiatry. 1996 Jun;153(6):812-5. No abstract available.

PMID:
8633695
[PubMed - indexed for MEDLINE]
19.

[Psychotic disorders and drug abuse in adolescents].

Fleischhaker C, Priemer K, Schulz E, Remschmidt H.

Z Kinder Jugendpsychiatr Psychother. 2002 May;30(2):87-95. German.

PMID:
12053878
[PubMed - indexed for MEDLINE]
20.

Clinical profiles, scope and general findings of the Western Sydney First Episode Psychosis Project.

Harris A, Brennan J, Anderson J, Taylor A, Sanbrook M, Fitzgerald D, Lucas S, Redoblado-Hodge A, Gomes L, Gordon E.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):36-43.

PMID:
15660704
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk